Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Addressing blinding in classic psychedelic studies with innovative active placebos

The International Journal of Neuropsychopharmacology(2025)10.1093/ijnp/pyaf023Source: DataRank Database

Addressing blinding in classic psychedelic studies with innovative active placebos is a research paper published in The International Journal of Neuropsychopharmacology (2025). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (21)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Otto Simonsson ORCID,Emmanuelle A. D. Schindler ORCID,Deepak Cyril D’Souza ORCID,Jacob S. Aday ORCID

Live enrichment

PubMed:40183712 PMC:PMC12038243

National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health

Grant: T32AR007080-44S1

NIAMS NIH HHS

Grant: T32 AR007080

National Institutes of Health

Grant: 3T32AR007080-45S1

Scientist Training in Rheumatology Research

Clusterbusters, Inc

VA R&D

Ceruvia Lifesciences

Wallace Research Foundation

Heffter Research Institute

Olle Engvist Foundation

Vikram Sodhi Endowed Chair of Psychiatry

goldLicense: cc-by-nc

publisherhttps://academic.oup.com/ijnp/advance-article-pdf/doi/10.1093/ijnp/pyaf023/62870584/pyaf023.pdf

publisherhttps://academic.oup.com/ijnp/article-pdf/28/4/pyaf023/62870584/pyaf023.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12038243

Europe_PMChttps://europepmc.org/articles/PMC12038243

Europe_PMChttps://europepmc.org/articles/PMC12038243?pdf=render

MeSH Terms

HumansHallucinogensPlacebosDouble-Blind MethodMental DisordersPlacebo EffectResearch DesignClinical Trials as Topic

Keywords

ReviewBlindingControl ConditionsPsychedelicsActive PlacebosPlacebosClinical Trials as TopicDouble-Blind MethodResearch DesignMental DisordersHallucinogensHumansPlacebo Effect